Its interaction promotes the recruitment of deubiquitinase ubiquitin-specific protease 11 (USP11), which inhibits CD133 polyubiquitination and its proteasomal degradation in small cell lung cancer (SCLC). This evidence concerns the gene PROM1 and small cell lung carcinoma.